FDA issue list of drug errors

The FDA has issued its monthly review of drug labelling errors, via their MedWatch Service. The list of errors relates to the following products: Exjade (deferasirox) Accupril (quinapril hydrochloride) Accuretic (quinapril HCL/hydrochlorothiazide) Arcapta Neohaler (indacaterol maleate) Avapro (irbesartan) Azor (amlodipine/olmesartan medoxomil) Benicar (olmesartan medoxomil) Benicar HCT (olmesartan medoxomil/hydrochlorothiazide) Cozaar (losartan potassium) Doxil (doxorubicin HCl liposome injection) Exforge (amlodipine/valsartan) Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) Hyzaar (losartan potassium/HCTZ) Juvisync (sitagliptin/simvastatin) Lotensin (benazepril HCl) Lotensin HCT (benazepril HCl and hydrochlorothiazide) Mavik (trandolapril) Multaq (dronedarone hydrochloride) Ozurdex (dexamethasone intravitreal implant) Tarka (trandolapril/verapamil hydrochloride) Teveten (Eprosartan Mesylate) Teveten HCT (eprosartan mesylate hydrochlorothiazide) Tribenzor (olmesartan medoxomil amlodipine/hydrochlorothiazide) Uniretic (moexipril hydrochloride/hydrochlorothiazide) Vaseretic (enalapril maleate/hydrochlorothiazide) Vasotec (enalapril maleate) Univasc (moexipril hydrochloride) Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) Aggrenox (aspirin/extended release dipyridamole) Cefepime for Injection Dexilant (dexlansoprazole) Foradil Aerolizer (formoterol fumarate inhalation powder) Lovaza (omega 3-acid ethyl esters) Maxipime (cefepime hydrochloride) Nexium (esomeprazole magnesium) Nexium I.V. (esomeprazole sodium) Prevacid (lansoprazole) Prilosec (omeprazole) Protonix (pantoprazole sodium) Trilipix (fenofibric acid) Vimovo (naproxen/esomeprazole magnesium) Xgeva (denosumab) Xyzal (levocetirizine dihydrochloride) Zomig (zolmitriptan) Zomig-ZMT (zolmitriptan) For further details, see FDA.